Ngā hua rapu - David Rog

  • E whakaatu ana i te 1 - 10 hua o te 10
Whakamahine hua
  1. 1
    Final analysis of 379 pregnancy outcomes after exposure to dimethyl fumarate in a prospective international registry

    Final analysis of 379 pregnancy outcomes after exposure to dimethyl fumarate in a prospective international registry mā Kerstin Hellwig, David Rog, Christopher McGuigan, Maria K. Houtchens, Denise R. Bruen, Oksana Mokliatchouk, Filipe Branco, Seth Levin, Nicholas Everage, Xiaochen Lin

    I whakaputaina 2024
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert group

    Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert group mā Chris McGuigan, M Craner, Joseph V. Guadagno, Raj Kapoor, Gordon Mazibrada, Paul Molyneux, Richard Nicholas, Jacqueline Palace, Owen Pearson, David Rog, Carolyn Young

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Anti-CD20 therapies in pregnancy and breast feeding: a review and ABN guidelines

    Anti-CD20 therapies in pregnancy and breast feeding: a review and ABN guidelines mā Ruth Dobson, David Rog, Caroline Ovadia, Katy Murray, Stella Hughes, Helen Ford, Owen Pearson, Sarah J. White, Nicola Bonham, Joela Mathews, Catherine Nelson‐Piercy, Peter Brex

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Prevalence, treatment and correlates of depression in multiple sclerosis

    Prevalence, treatment and correlates of depression in multiple sclerosis mā Carolyn Young, Dawn Langdon, David Rog, Suresh Kumar Chhetri, Radu Tanasescu, Seema Kalra, Gillian Webster, Richard Nicholas, Helen Ford, John Woolmore, David Paling, Alan Tennant, Roger Mills

    I whakaputaina 2024
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies

    COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies mā Afagh Garjani, Rod Middleton, Rachael Hunter, Katherine Tuite-Dalton, Alasdair Coles, Ruth Dobson, Martin Duddy, Stella Hughes, Owen Pearson, David Rog, Emma Tallantyre, Roshan das Nair, Richard Nicholas, Nikos Evangelou

    I whakaputaina 2021
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Self-diagnosed COVID-19 in people with multiple sclerosis: a community-based cohort of the UK MS Register

    Self-diagnosed COVID-19 in people with multiple sclerosis: a community-based cohort of the UK MS Register mā Nikos Evangelou, Afagh Garjani, Roshan das Nair, Rachael Hunter, Katherine Tuite-Dalton, Elaine Craig, Jeff Rodgers, Alasdair Coles, Ruth Dobson, Martin Duddy, David Ford, Stella Hughes, Owen Pearson, Linda Middleton, David Rog, Emma Tallantyre, Tim Friede, Rod Middleton, Richard Nicholas

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Carta
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Pregnancy outcomes and postpartum relapse rates in women with RRMS treated with alemtuzumab in the phase 2 and 3 clinical development program over 16 years

    Pregnancy outcomes and postpartum relapse rates in women with RRMS treated with alemtuzumab in the phase 2 and 3 clinical development program over 16 years mā Jiwon Oh, Anat Achiron, Elisabeth Gulowsen Celius, Christina Chambers, Joy Derwenskus, Virginia Devonshire, Kerstin Hellwig, George J. Hutton, Pamela McCombe, Marie Moore, David Rog, Jean-Raphael Schneider, Renata Simm, Lívia Sousa, Stephen G. Vincent, Luke Chung, Nadia Daizadeh, Colin Mitchell, D. A. S. Compston

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Validating the portal population of the United Kingdom Multiple Sclerosis Register

    Validating the portal population of the United Kingdom Multiple Sclerosis Register mā Rod Middleton, Jeff Rodgers, Jeremy Chataway, Klaus Schmierer, David Rog, Ian Galea, Ashley Akbari, Katie Tuite-Dalton, Hazel Lockhart-Jones, D. J. Griffiths, David G. Noble, Kerina Jones, A. S. Najim Al-Din, Matt Craner, Nikos Evangelou, Paula Harman, Timothy Harrower, Jeremy Hobart, H. Husseyin, Marianne Kasti, Christopher Kipps, Gavin McDonnell, Charlotte Owen, Owen Pearson, Waqar Rashid, Heather Wilson, David Ford

    I whakaputaina 2018
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study

    Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study mā J William L Brown, Nick Cunniffe, Ferrán Prados, Baris Kanber, Joanne L. Jones, Edward Needham, Zoya Georgieva, David Rog, Owen Pearson, James Overell, David MacManus, Rebecca S. Samson, Jonathan Stutters, Charles ffrench‐Constant, Claudia A. M. Gandini Wheeler‐Kingshott, Carla Moran, Paul D. Flynn, Andrew W. Michell, Robin J.M. Franklin, Siddharthan Chandran, Daniel R. Altmann, Declan Chard, Peter Connick, Alasdair Coles

    I whakaputaina 2021
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK

    Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised... mā James Blackstone, Thomas Williams, Jennifer Nicholas, Ekaterina Bordea, Floriana De Angelis, Alessia Bianchi, Alberto Calvi, Anisha Doshi, Nevin John, Sean Apap Mangion, Charles E. Wade, Rachel Merry, Gil Barton, Dawn Lyle, Elisabeth Jarman, Don J. Mahad, Abdullah Shehu, Tarunya Arun, Gavin McDonnell, Ruth Geraldes, Matthew Craner, Charles Hillier, Jeban Ganesalingam, Leonora Fisniku, Jeremy Hobart, Cord Spilker, Neil Robertson, Seema Kalra, Stefano Pluchino, Sreedharan Harikrishnan, Miriam Mattoscio, Timothy Harrower, Carolyn Young, Martin L. Lee, Suresh Kumar Chhetri, Fayyaz Ahmed, David Rog, Eli Silber, Paul W. Gallagher, Martin Duddy, Agne Straukiene, Nicholas Richard, Claire M Rice, Stuart J Nixon, Judy Beveridge, Annie Hawton, Susan Tebbs, Marie Braisher, Gavin Giovannoni, Olga Ciccarelli, John Greenwood, Alan J. Thompson, Rachael Hunter, Sue Pavitt, Owen Pearson, Nikos Evangelou, Basil Sharrack, Ian Galea, Siddharthan Chandran, Helen Ford, Chris Frost, Jeremy Chataway

    I whakaputaina 2024
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: